Article
EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
2020-05-18
Abstract excerpt
<title>Abstract</title> <p><bold>BACKGROUND: </bold>Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer that lacks expression of estrogen receptor (ER) and progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) gene. Chemotherapy remains the standard of care for TNBC treatment, but considerable patients are very resistant to chemotherapy. Mutations or a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2a5c7070-cad4-5d0e-9d4d-cd673ab40618
- DOI
- 10.21203/rs.3.rs-16904/v2
